EW
Edward White HC Wainwright & Co. Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Cullinan Oncology
CGEM
$404M
| $6.84 | $33 |
382%
upside
| Buy |
16 Apr ‘25
4 months ago |
|
|
VALN
2
Valneva
VALN
$732M
| $8.52 | $17 |
100%
upside
| Buy |
15 Apr ‘25
4 months ago |
|
|
NYXH
3
Nyxoah
NYXH
$219M
| $5.84 | $15 |
157%
upside
| Buy |
8 Apr ‘25
5 months ago |
|
4
SAB Biotherapeutics
SABS
$21.9M
| $2.10 | $6 |
186%
upside
| Buy |
1 Apr ‘25
5 months ago |
|
5
Curis
CRIS
$21.4M
| $1.71 | $16 |
836%
upside
| Buy |
31 Mar ‘25
5 months ago |
|
6
Sensei Biotherapeutics
SNSE
$10M
| $7.93 | $80 |
909%
upside
| Buy |
28 Mar ‘25
5 months ago |
|
|
ARTV
7
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$75.5M
| $3.09 | $20 |
547%
upside
| Buy |
26 Mar ‘25
5 months ago |
|
8
Larimar Therapeutics
LRMR
$336M
| $3.93 | $16 |
307%
upside
| Buy |
25 Mar ‘25
5 months ago |
|
9
Aura Biosciences
AURA
$402M
| $6.47 | $25 |
286%
upside
| Buy |
25 Mar ‘25
5 months ago |
|
10
InflaRx
IFRX
$107M
| $1.58 | $8 |
406%
upside
| Buy |
21 Mar ‘25
5 months ago |
|
11
TG Therapeutics
TGTX
$5.14B
| $32.38 | $55 |
70%
upside
| Buy |
4 Mar ‘25
6 months ago |
|
12
Syndax Pharmaceuticals
SNDX
$1.41B
| $16.33 | $51 |
212%
upside
| Buy |
4 Mar ‘25
6 months ago |
|
13
Puma Biotechnology
PBYI
$230M
| $4.56 | $7 |
54%
upside
| Buy |
28 Feb ‘25
6 months ago |
|
14
Karyopharm Therapeutics
KPTI
$54.2M
| $6.25 | $56 |
796%
upside
| Buy |
26 Feb ‘25
6 months ago |
|
15
Dynavax Technologies
DVAX
$1.14B
| $9.70 | $31 |
220%
upside
| Buy |
21 Feb ‘25
6 months ago |
|
16
Spyre Therapeutics
SYRE
$1B
| $16.63 | $25 |
50%
upside
| Neutral |
3 Mar ‘23
2 years ago |
|
|
RNTX
17
Rein Therapeutics, Inc. Common Stock
RNTX
$31.2M
| $1.34 | $20 |
1,393%
upside
| Buy |
30 Jun ‘22
3 years ago |
|
18
Mersana Therapeutics
MRSN
$35.1M
| $7.04 | $700 |
9,843%
upside
| Buy |
30 Aug ‘21
4 years ago |
|
19
IDEAYA Biosciences
IDYA
$2.05B
| $23.39 | $30 |
28%
upside
| Buy |
11 Aug ‘21
4 years ago |
|